EligibleTrials

Clinical trials recruiting for Esophagus Cancer

9
Recruiting trials
5
US states with sites
11
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 1Not applicable 5

Drugs and treatments being studied

InterventionTrials
CEA-targeted CAR-T cells2
CEA CAR-T cells1
For injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate1
Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetate1
[18F]F-RESCA-G51
[18F]F-RESCA-RB141
[18F]F-RESCA-RND201
[18F]F-RESCA-T41
[18F]F-RESCA-WWH3471
[68Ga]Ga-DOTA-H2D31
[68Ga]Ga-NOTA-G51
[68Ga]Ga-NOTA-RND201

Where trials are recruiting (top US states)

StateRecruiting trials
California1
New Hampshire1
Pennsylvania1
Texas1
Wisconsin1

Top cities

Houston, Texas 1Lebanon, New Hampshire 1Los Angeles, California 1Milwaukee, Wisconsin 1Pittsburgh, Pennsylvania 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Esophagus Cancer often also study these conditions. Each links to its own recruiting-trial list.

Pancreatic cancer 870Colorectal cancer 1359Pancreas Cancer 86Lung cancer 2180Liver cancer 43Gastric cancer 91Colon cancer 96Breast cancer 2239Rectal cancer 152Appendix Cancer 4

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Esophagus Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.